Healthcare - Biotechnology - NASDAQ - US
$ 0.253
-38.3 %
$ 451 K
Market Cap
-0.02
P/E
BALANCE SHEET
8.59 M
ASSETS
5.08 M
LIABILITIES
3.51 M
EQUITY
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition
NexImmune, Inc.
| Current Assets | 5.4 M |
| Cash & Short-Term Investments | 4.65 M |
| Receivables | 0 |
| Other Current Assets | 754 K |
| Non-Current Assets | 3.19 M |
| Long-Term Investments | 0 |
| PP&E | 1.4 M |
| Other Non-Current Assets | 1.79 M |
| Current Liabilities | 5.08 M |
| Accounts Payable | 1.34 M |
| Short-Term Debt | 68.8 K |
| Other Current Liabilities | 3.68 M |
| Non-Current Liabilities | 0 |
| Long-Term Debt | 0 |
| Other Non-Current Liabilities | 0 |
Balance Sheet
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | |
|---|---|---|---|---|---|---|
| ASSETS | ||||||
| Cash & Cash Equivalents | 3.2 | 34.6 | 30.3 | 5.0 | 9.1 | 0.4 |
| Short Term Investments | 1.4 | 0 | 51.5 | 0 | 1.0 | 11.6 |
| Receivables | 0 | 74.5 K | 0 | 0 | 6.42 K | 73.6 K |
| Inventory | 0 | 19.5 K | 0 | 0 | 61.1 K | 0 |
| Other Current Assets | 0.8 | 2.7 | 4.4 | 2.3 | 0.9 | 0.2 |
| Total Current Assets | 5.4 | 37.4 | 86.3 | 8.4 | 11.0 | 12.3 |
| PP&E | 1.4 | 5.4 | 4.4 | 2.9 | 2.6 | 1.7 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Long Term Assets | 1.8 | 0.3 | 0.3 | 23.4 K | 0.1 | 0.1 |
| Other Assets | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Assets | 8.6 | 43.1 | 91.0 | 11.3 | 13.7 | 14.1 |
| LIABILITIES | ||||||
| Accounts Payable | 1.3 | 2.4 | 1.0 | 2.8 | 1.2 | 0.9 |
| Short Term Debt | 68.8 K | 0.6 | 0 | 19.1 | 0 | 0 |
| Other Current Liabilities | 3.7 | 7.4 | 6.2 | 5.1 | 1.9 | 2.1 |
| Total Current Liabilities | 5.1 | 10.3 | 7.2 | 27.0 | 3.0 | 3.0 |
| Long Term Debt | 0 | 0.4 | 0 | 0 | 0 | 0 |
| Deferred Tax Income | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Liabilities | 0 | 0 | 55.6 K | 28.5 K | 81.9 K | 0.3 |
| Total Liabilities | 5.1 | 10.8 | 7.3 | 27.1 | 3.1 | 3.3 |
| EQUITY | ||||||
| Common Stock | 2.65 K | 2.61 K | 2.28 K | 126 | 126 | 117 |
| Retained Earnings | (222.6) | (190.2) | (127.7) | (77.6) | (47.7) | (27.2) |
| Other Accumulative Comprehensive Income/Loss | 0 | 0 | 3.01 K | 0 | 506 | 29.5 K |
| Total Equity | 3.5 | 32.3 | 83.8 | (15.8) | 10.6 | 10.8 |
| Total Liabilities and Equity | 8.6 | 43.1 | 91.0 | 11.3 | 13.7 | 14.1 |
| SHARES OUTSTANDING | ||||||
| Common Shares Outstanding | 1.0 | 1.0 | 0.9 | 0.9 | 0.9 | 0.9 |